The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis In Vitro and Induces Vasodilatation Without Desensitisation In Vivo. (2020)
Attributed to:
Maximising patient benefit: Leeds’ Interdisciplinary approach to translation (CiC 2016)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2020.588669
PubMed Identifier: 33716722
Publication URI: http://europepmc.org/abstract/MED/33716722
Type: Journal Article/Review
Volume: 11
Parent Publication: Frontiers in pharmacology
ISSN: 1663-9812